Published in Inflammopharmacology on July 12, 2013
Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations. Chest (2015) 0.89
Chemokines in chronic liver allograft dysfunction pathogenesis and potential therapeutic targets. Clin Dev Immunol (2013) 0.78
Dietary phytochemicals modulate skin gene expression profiles and result in reduced lice counts after experimental infection in Atlantic salmon. Parasit Vectors (2016) 0.76
Microarray expression profiling identifies genes, including cytokines, and biofunctions, as diapedesis, associated with a brain metastasis from a papillary thyroid carcinoma. Am J Cancer Res (2016) 0.75
Sputum RNA signature in allergic asthmatics following allergen bronchoprovocation test. Eur Clin Respir J (2016) 0.75
Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med (1998) 12.80
Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A (2003) 6.06
Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol (2004) 4.72
Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood (2002) 3.58
Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol (2007) 3.43
Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol (2008) 3.04
The airway epithelium in asthma. Nat Med (2012) 2.86
The chemokine superfamily revisited. Immunity (2012) 2.83
Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol (2003) 2.62
Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J (2008) 1.78
Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5- phenotype. J Immunol (2007) 1.77
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol (2000) 1.72
The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev (1999) 1.57
Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood (2000) 1.51
Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur J Immunol (2002) 1.44
Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med (1996) 1.38
Therapeutic targeting of chemokine interactions in atherosclerosis. Nat Rev Drug Discov (2010) 1.38
Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol (1999) 1.28
CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges. Pharmacol Rev (2013) 1.27
Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation. J Biol Chem (2006) 1.24
Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest (1997) 1.22
Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ Res (2004) 1.19
CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen. J Immunol (2005) 1.18
Chemokines and atherosclerosis. Ann Med (2004) 1.14
Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J Leukoc Biol (1997) 1.12
CCR3 expression and function in asthmatic airway smooth muscle cells. J Immunol (2005) 1.08
Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol (2000) 1.08
Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease. J Immunol (2000) 1.06
Impaired lung dendritic cell activation in CCR2 knockout mice. Am J Pathol (2004) 1.04
Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines. Am J Respir Crit Care Med (2000) 0.97
Monocyte chemotactic protein-4 (MCP-4; CCL-13): a biomarker of asthma. J Asthma (2004) 0.95
Targeting chemokine receptors in allergic disease. Biochem J (2011) 0.95
The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations. Immunol Allergy Clin North Am (2008) 0.94
Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis. Arthritis Rheum (2009) 0.93
Detection of human MCP-4/CCL13 isoforms by SELDI immunoaffinity capture. J Transl Med (2006) 0.87
Role of monocyte chemotactic protein-3 and -4 in children with virus exacerbation of asthma. Eur Respir J (2008) 0.86
Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: effect of topical corticosteroids. J Allergy Clin Immunol (1999) 0.85
Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts. Ann Allergy Asthma Immunol (2010) 0.84
Entamoeba histolytica cysteine protease 2 (EhCP2) modulates leucocyte migration by proteolytic cleavage of chemokines. Parasite Immunol (2004) 0.84
Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Cardiovasc Res (2010) 0.84
Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice. Br J Pharmacol (2005) 0.83
Monocyte chemotactic protein-4: tissue-specific expression and signaling through CC chemokine receptor-2. J Leukoc Biol (1997) 0.83
Genomic organization, sequence analysis and transcriptional regulation of the human MCP-4 chemokine gene (SCYA13) in dermal fibroblasts: a comparison to other eosinophilic beta-chemokines. Biochem Biophys Res Commun (1999) 0.83
Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects. Obesity (Silver Spring) (2006) 0.83
Expression and regulation of CCR1 by airway smooth muscle cells in asthma. J Immunol (2008) 0.83
Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis. Genes Immun (2009) 0.83
Estrogen inhibits apoptosis and promotes CC motif chemokine ligand 13 expression on synovial fibroblasts in rheumatoid arthritis. Immunopharmacol Immunotoxicol (2012) 0.82
A role of monocyte chemoattractant protein-4 (MCP-4)/CCL13 from chondrocytes in rheumatoid arthritis. FEBS J (2007) 0.81
Analysis of the antimicrobial activities of a chemokine-derived peptide (CDAP-4) on Pseudomonas aeruginosa. Biochem Biophys Res Commun (2007) 0.81
Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis. Rheumatology (Oxford) (2005) 0.80
IL-4 differentially regulates eotaxin and MCP-4 in lung epithelium and circulating mononuclear cells. Am J Physiol Lung Cell Mol Physiol (2001) 0.80
CC motif chemokine ligand 13 is associated with rheumatoid arthritis pathogenesis. Mod Rheumatol (2012) 0.80
Monocyte chemoattractant protein-4 core promoter genetic variants: influence on YY-1 affinity and plasma levels. Am J Respir Cell Mol Biol (2003) 0.80
Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma. Bioorg Med Chem Lett (2007) 0.79
The monocyte chemotactic protein-4 induces oxygen radical production, actin reorganization, and CD11b up-regulation via a pertussis toxin-sensitive G-protein in human eosinophils. Biochem Biophys Res Commun (1997) 0.79
Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression. J Neuroimmunol (2009) 0.79
CDIP-2, a synthetic peptide derived from chemokine (C-C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation. Clin Exp Immunol (2008) 0.78
Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists. Immunobiology (2009) 0.78
Small molecule antagonists of chemokine receptors--is promiscuity a virtue? Curr Top Med Chem (2010) 0.77
Physical mapping of the CC-chemokine gene cluster on the human 17q11. 2 region. Genomics (1999) 0.77
Structure of human monocyte chemoattractant protein 4 (MCP-4/CCL13). Acta Crystallogr D Biol Crystallogr (2008) 0.77
Expression of MCP-4 by TLR ligand-stimulated nasal polyp fibroblasts. Acta Otolaryngol (2007) 0.76
[Pathogenesis of asthma]. Nihon Rinsho (2005) 0.75
Trichinella spiralis: intranasal immunization with attenuated Salmonella enterica carrying a gp43 antigen-derived 30mer epitope elicits protection in BALB/c mice. Exp Parasitol (2011) 0.84
CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis. Immunobiology (2012) 0.78
Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists. Immunobiology (2009) 0.78
CDIP-2, a synthetic peptide derived from chemokine (C-C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation. Clin Exp Immunol (2008) 0.78